Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study

The Lancet HIV

Volumn 3, Issue 9, 2016, Pages e441-e448

  McGillen, Jessica B ^a   Anderson, Sarah Jane ^a   Dybul, Mark R ^b   Hallett, Timothy B ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Global Fund   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DISEASE TRANSMISSION; FEMALE; GEOGRAPHY; HEALTH CARE COST; HETEROSEXUAL MALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MALE; MATHEMATICAL MODEL; MEN WHO HAVE SEX WITH MEN; PREVALENCE; PRIORITY JOURNAL; RESOURCE ALLOCATION; SEXUAL BEHAVIOR; ECONOMICS; EPIDEMIC; GLOBAL HEALTH; HIV INFECTIONS; MIDDLE AGED; THEORETICAL MODEL; TRANSMISSION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; EPIDEMICS; FEMALE; GLOBAL HEALTH; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, THEORETICAL; PREVALENCE; RESOURCE ALLOCATION; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 84991581682     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(16)30051-0     Document Type: Article

References (30)

1. 1 Piot, P, Karim, SSA, Hecht, R, et al. A UNAIDS–Lancet Commission on Defeating AIDS—Advancing Global Health. Lancet 386 (2015), 171–218.
2. 2 Collier, P, Sterck, O, Manning, R, CSAE Working Paper WPS/2015-16. The moral and fiscal implications of anti-retroviral therapies for HIV in Africa. http://www.economics.ox.ac.uk/materials/papers/13850/csae-wps-2015-05.pdf, February, 2015 (accessed July 20, 2016).
3. 3 Jones, A, Cremin, I, Abdullah, F, et al. Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention. Lancet 384 (2014), 272–279.
4. 4 US Agency for International Development. Demographic and Health Surveys (DHS). http://www.dhsprogram.com/, 2015 (accessed July 20, 2016).
5. 5 Baral, S, Beyrer, C, Muessig, K, et al. Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis 12 (2012), 538–549.
6. 6 Beyrer, C, Baral, SD, van Griensven, F, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet 380 (2012), 367–377.
7. 7 Resch, S, Ryckman, T, Hecht, R, Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries. Lancet Glob Health 3 (2015), e52–e61.
8. 8 Gerberry, DJ, Wagner, BG, Garcia-Lerma, JG, Heneine, W, Blower, S, Using geospatial modelling to optimise the rollout of antiretroviral-based pre-exposure HIV interventions in sub-Saharan Africa. Nat Commun, 5, 2014, 5454.
9. 9 Fraser, N, Kerr, C, Harouna, Z, et al. Reorienting the HIV response in Niger toward sex work interventions: from better evidence to targeted and expanded practice. J Acquir Immune Defic Syndr 68 (2015), S213–S220.
10. 10 The Global Fund. The Global Fund strategy in relation to sexual orientation and gender identities, 2015, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland.
11. 11 Verguet, S, Stalcup, M, Walsh, J, Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?. Sex Transm Infect 89 (2013), 628–634.
12. 12 Gomez, GB, Borquez, A, Case, KK, Wheelock, A, Vassall, A, Hankins, C, The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. PLoS Med, 10, 2013, e1001401.
13. 13 Awad, SF, Sgaier, SK, Tambatamba, BC, et al. Investigating voluntary medical male circumcision program efficiency gains through subpopulation prioritization: insights from application to Zambia. PLoS One, 10, 2015, e0145729.
14. 14 Long, EF, Stavert, RR, Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis. J Gen Intern Med 29 (2013), 1294–1301.
15. 15 Cremin, I, Alsallaq, R, Dybul, M, Piot, P, Garnett, G, Hallett, TB, The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. AIDS 27 (2013), 447–458.
16. 16 Kerr, CC, Stuart, RM, Gray, RT, et al. Optima: a model for HIV epidemic analysis, program prioritization, and resource optimization. J Acquir Immune Defic Syndr 69 (2015), 365–376.
17. 17 Anderson, S-J, Cherutich, P, Kilonzo, N, et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet 384 (2014), 249–256.
18. 18 Hallett, T, Singh, K, Smith, JA, White, RG, Abu-Raddad, LJ, Garnett, GP, Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One, 3, 2008, e2212.
19. 19 Hallett, T, Gregson, S, Mugurungi, O, et al. Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to data from Zimbabwe. Epidemics 1 (2009), 108–117.
20. 20 AIDSinfo. Offering information on HIV/AIDS treatment, prevention, and research. http://aidsinfo.unaids.org/, 2015 (accessed July 20, 2016).
21. 21 Ellman, T, Demedicalizing AIDS prevention and treatment in Africa. N Engl J Med 372 (2015), 303–305.
22. 22 AVERTing HIV and AIDS. Funding for HIV and AIDS, 2010, AVERT, Brighton.
23. 23 UNAIDS. Fast track: ending the AIDS epidemic by 2030, 2014, UNAIDS, Geneva.
24. 24 The African Union. The roadmap: shared responsibility and global solidarity for AIDS, TB, and malaria response in Africa, 2013, African Union, Addis Ababa.
25. 25 McGovern, ME, Bärnighausen, T, Salomon, JA, Canning, D, Using interviewer random effects to remove selection bias from HIV prevalence estimates. BMC Med Res Methodol, 15, 2015, 8.
26. 26 Eaton, JW, Rehle, TM, Jooste, S, et al. Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa: implications for HIV estimates. AIDS 28 (2014), S507–S514.
27. 27 Coffee, M, Lurie, M, Garnett, G, Modelling the impact of migration on the HIV epidemic in South Africa. AIDS 21 (2007), 343–350.
28. 28 Mathers, BM, Degenhardt, L, Phillips, B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 372 (2008), 1733–1745.
29. 29 Harrison, A, Colvin, C, Kuo, C, Swartz, A, Lurie, M, Sustained high HIV incidence in young women in southern Africa: social, behavioural, and structural factors and emerging intervention approaches. Curr HIV/AIDS Rep 12 (2015), 207–215.
30. 30 Linard, C, Gilbert, M, Snow, R, Noor, A, Tatem, A, Population distribution, settlement patterns, and accessibility across Africa in 2010. PLoS One, 7, 2012, e31743.